The University awarded a contract for sequencing reagents.

Award Info Published Tuesday July 26, 2022Illumina Inc., San Diego, CAAmount: An estimated $325,000Terms: An estimated start date of 7/25/2022 through 6/30/2025Renewals: NoneSummaryVendors1total0BEP vendors0VBP vendors0Small businessesThe University award process may be delayed up to thirty days as this award goes through a state approval process. First published Tuesday, July 26, 2022 The University awarded a contract for sequencing reagents. Sequencing reagents to be used with next-generation sequencing instrumentation. This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for performing sponsored research and other sponsored activities under grants and contracts funded by the sponsor or by sources other than State appropriations. (30 ILCS 500 / 1-13(b)(8)) The laboratory operates two Illumina NGS sequencing instruments (MiniSeq and MiSeq) and these reagents are exclusive to Illumina. The Illumina line of NGS instrumentation is a golden standard for advanced sequencing applications. We stride to deliver the the most up to date technologies to the University. For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:Jeffrey Walsh University of Illinois at Chicago Purchasing Division (M/C 560) 809 South Marshfield Avenue Chicago, IL 60612-7203 Phone: (312) 355-3568 FAX: (312) 996-3135 Purchasing